Information Provided By: 
Fly News Breaks for June 29, 2017
AGN, SRPT
Jun 29, 2017 | 07:28 EDT
Credit Suisse analyst Alethia Young said Sarepta's (SRPT) selection of Doug Ingram, an established industry veteran and a former president at Allergan (AGN), as its new CEO is a positive, noting that Ingram has experience both in the CNS space and at running a large scale pharmaceutical company. Young, who would guess that the hiring will be viewed positively and sees Sarepta shares trading up following the news, keeps an Outperform rating and $64 price target on the stock.
News For SRPT;AGN From the Last 2 Days
There are no results for your query SRPT;AGN
